neoplasm
• mice are resistant to the carcinogen N-nitrosodiethylamine (DEN) or DEN plus phenobarbital (PB) induced hepatocellular carcinoma (HCC)
• following treatment, mice develop either no tumors or very small tumors
• DEN+PB treatment produces some level of dysplasia, but not HCC
|
• spontaneous lung, heart and liver tumors are not observed in 16 month old mice
• macrophage infiltration of the liver is not observed in aged (16 month old) mice
|
• 16 month old mice do not develop spontaneous myxoma as compared to wild-type
|
• 16 month old mice do not develop spontaneous lymphoma and adenocarcinoma as compared to wild-type
|
• 16 month old mice do not develop spontaneous adenocarcinoma and carcinoid tumors as compared to wild-type
|
cellular
• macrophage infiltration of the liver is not observed in aged (16 month old) mice
|
hematopoietic system
• macrophage infiltration of the liver is not observed in aged (16 month old) mice
|
homeostasis/metabolism
• mice are resistant to the carcinogen N-nitrosodiethylamine (DEN) or DEN plus phenobarbital (PB) induced hepatocellular carcinoma (HCC)
• following treatment, mice develop either no tumors or very small tumors
• DEN+PB treatment produces some level of dysplasia, but not HCC
|
immune system
• macrophage infiltration of the liver is not observed in aged (16 month old) mice
|
• LPS-mediated IL1beta induction is blunted in comparison to wild-type
|
• LPS-mediated IL6 induction is blunted in comparison to wild-type
|
liver/biliary system
• 16 month old mice do not develop spontaneous lymphoma and adenocarcinoma as compared to wild-type
|
cardiovascular system
• 16 month old mice do not develop spontaneous myxoma as compared to wild-type
|
reproductive system
respiratory system
• 16 month old mice do not develop spontaneous adenocarcinoma and carcinoid tumors as compared to wild-type
|